npj Schizophrenia is an open access, online-only journal that aims to publish high-quality original papers and review articles relevant to all aspects of schizophrenia and psychosis, from molecular and basic research through environmental or social research, to translational and treatment-related topics. npj Schizophrenia publishes papers on the broad psychosis spectrum including affective psychosis, bipolar disorder, the at-risk mental state, psychotic symptoms, and overlap between psychotic and other disorders.
npj Schizophrenia is published in partnership between The Schizophrenia International Research Society and Nature Publishing Group. Authors whose papers are accepted for publication within npj Schizophrenia are required to pay an article processing charge (APC). All SIRS members are entitled to a discounted APC (50% reduction on the full rate) if an article for which they are the corresponding author is accepted for publication within the journal. Visit the website to explore all content available: www.nature.com/npjschz Explore the benefits of submitting your next manuscript: https://www.nature.com/npjschz/about/apc
29 June, 2020 – npj Schizophrenia Receives its First Impact Factor
The Schizophrenia International Research Society’s (SIRS) partner journal, npj Schizophrenia, received its first Impact Factor on Tuesday, 29 June. The first Impact factor is 4.304. The journal has a ranking of 34 of 155 in psychiatry journals. npj Schizophrenia is part of the Nature Partner Journals series and is published by Springer Nature in partnership with SIRS.
npj Schizophrenia Editor-in-Chief, James H. Meador-Woodruff, stated, “It is exciting for our society journal, npj Schizophrenia, to have just received its first impact factor of 4.304. It takes several years from the time a journal is started to accumulate a critical mass of publications and subsequent citations to be included in indexing services, and then a few more years to get to this point of a first official impact factor. It has been a team effort by many to reach this milestone, and my sincere thanks to our editorial board and exceptional team of associate editors, as well as our publishing partners at Springer Nature. But most important, the journal would not have been successful without the support of many of the members of SIRS who have submitted manuscripts to a new and untested journal, and even more members who have provided expert peer review. A big “thank you” to all of you that have been part of this journey so far. Now that we have achieved this recognition and visibility, I hope that all of you will consider npj Schizophrenia as a journal in which to publish. Publishing outstanding research from members of our society will be important as we take this journal to the next level.”